These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 27488866)

  • 1. Optimal control therapy and vaccination for special HIV-1 model with delay.
    Shamsara E; Shamsara J; Afsharnezhad Z
    Theory Biosci; 2016 Dec; 135(4):217-230. PubMed ID: 27488866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling IL-7 Injections in HIV-Infected Patients.
    Pasin C; Dufour F; Villain L; Zhang H; Thiébaut R
    Bull Math Biol; 2018 Sep; 80(9):2349-2377. PubMed ID: 30073567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical Model for an Effective Management of HIV Infection.
    Ogunlaran OM; Oukouomi Noutchie SC
    Biomed Res Int; 2016; 2016():4217548. PubMed ID: 27057541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and Long-Term Optimal Control of a Mathematical Model for HIV Infection of CD4+T Cells.
    Croicu AM
    Bull Math Biol; 2015 Nov; 77(11):2035-71. PubMed ID: 26493544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the intra-host dynamics of HIV-1 infections.
    Stilianakis NI; Schenzle D
    Math Biosci; 2006 Jan; 199(1):1-25. PubMed ID: 16343556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mathematical model of cell-to-cell spread of HIV-1 that includes a time delay.
    Culshaw RV; Ruan S; Webb G
    J Math Biol; 2003 May; 46(5):425-44. PubMed ID: 12750834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.
    Ensoli B; Nchabeleng M; Ensoli F; Tripiciano A; Bellino S; Picconi O; Sgadari C; Longo O; Tavoschi L; Joffe D; Cafaro A; Francavilla V; Moretti S; Pavone Cossut MR; Collacchi B; Arancio A; Paniccia G; Casabianca A; Magnani M; Buttò S; Levendal E; Ndimande JV; Asia B; Pillay Y; Garaci E; Monini P;
    Retrovirology; 2016 Jun; 13(1):34. PubMed ID: 27277839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failure.
    Kent SJ; Greenberg PD; Hoffman MC; Akridge RE; McElrath MJ
    J Immunol; 1997 Jan; 158(2):807-15. PubMed ID: 8992998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase-1-Mediated Pyroptosis of the Predominance for Driving CD4[Formula: see text] T Cells Death: A Nonlocal Spatial Mathematical Model.
    Wang W; Zhang T
    Bull Math Biol; 2018 Mar; 80(3):540-582. PubMed ID: 29349609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oscillatory viral dynamics in a delayed HIV pathogenesis model.
    Wang Y; Zhou Y; Wu J; Heffernan J
    Math Biosci; 2009 Jun; 219(2):104-12. PubMed ID: 19327371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal HIV treatment by maximising immune response.
    Culshaw RV; Ruan S; Spiteri RJ
    J Math Biol; 2004 May; 48(5):545-62. PubMed ID: 15133623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses.
    Andrés C; Plana M; Guardo AC; Alvarez-Fernández C; Climent N; Gallart T; León A; Clotet B; Autran B; Chomont N; Gatell JM; Sánchez-Palomino S; García F
    J Virol; 2015 Sep; 89(18):9189-99. PubMed ID: 26109727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulse HIV vaccination: feasibility for virus eradication and optimal vaccination schedule.
    Yang Y; Xiao Y; Wu J
    Bull Math Biol; 2013 May; 75(5):725-51. PubMed ID: 23535904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dual role of CD4 T helper cells in the infection dynamics of HIV and their importance for vaccination.
    Altes HK; Wodarz D; Jansen VA
    J Theor Biol; 2002 Feb; 214(4):633-46. PubMed ID: 11851372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus dynamics model with intracellular delays and immune response.
    Song H; Jiang W; Liu S
    Math Biosci Eng; 2015 Feb; 12(1):185-208. PubMed ID: 25811332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal Control of a Delayed SIRS Epidemic Model with Vaccination and Treatment.
    Laarabi H; Abta A; Hattaf K
    Acta Biotheor; 2015 Jun; 63(2):87-97. PubMed ID: 25578405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immuno-modulatory strategies for reduction of HIV reservoir cells.
    Banks HT; Flores KB; Hu S; Rosenberg E; Buzon M; Yu X; Lichterfeld M
    J Theor Biol; 2015 May; 372():146-58. PubMed ID: 25701451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of HIV persistence: implications for vaccines and therapy.
    Bremermann HJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(5):459-83. PubMed ID: 7627623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A stochastic model for early HIV-1 population dynamics.
    Tuckwell HC; Le Corfec E
    J Theor Biol; 1998 Dec; 195(4):451-63. PubMed ID: 9837702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load.
    Lévy Y; Thiébaut R; Montes M; Lacabaratz C; Sloan L; King B; Pérusat S; Harrod C; Cobb A; Roberts LK; Surenaud M; Boucherie C; Zurawski S; Delaugerre C; Richert L; Chêne G; Banchereau J; Palucka K
    Eur J Immunol; 2014 Sep; 44(9):2802-10. PubMed ID: 25042008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.